Patent
Provided herein are compositions and methods for improved production of steviol glycosides in a host cell. In some embodiments, the host cell is genetically modified to comprise a heterologous nucleotide sequence encoding a Stevia rebaudiana kaurenoic acid hydroxylase. In some embodiments, the host cell further comprises one or more heterologous nucleotide sequence encoding further enzymes of a pathway capable of producing one or more steviol glycosides in the host cell. The compositions and methods described herein provide an efficient route for the heterologous production of steviol glycosides, including but not limited to, rebaudioside D and rebaudioside M.
1. A kaurenoic acid hydroxylase polypeptide with residue numbers according to SEQ ID NO: 1, comprising:
one, two, three, four, five, six, seven, eight, nine, or ten, of the following mutations: I166R, I153L, S158D, G306L, L232D, 1333V, 1350L, V316L, G447V, and M308L,
wherein the kaurenoic acid hydroxylase polypeptide is capable of increased conversion of kaurenoic acid to steviol compared to a kaurenoic acid hydroxylase polypeptide of SEQ ID NO:1.
2. The kaurenoic acid hydroxylase polypeptide of claim 1 comprising the following mutations:
(a) I166R and I333V,
(b) I166R, 1350L, and G447V,
(c) I153L, S158D, 1166R, L232D, 1333V, and I350L,
(d) S158D, G306L, and 1350L,
(e) G306L, V316L, 1350L, and G447V,
(f) G306L, V316L, 1333V, and I350,
(g) S158D, 1166R, L232D, G306L, and I333V,
(h) L232D, G306L, V316L, 1333V, and 1350,
(i) I166R, L232D, G306L, and 1350L, or
(j) S158D, 1166R, G306L, M308L, V316L, and 1350L.
3. The kaurenoic acid hydroxylase polypeptide of claim 1 , further comprising at least one mutation at kaurenoic acid hydroxylase positions E492C, M427A, G306D, V333C, D191L, 140S, L445I, S114A, D191Y, D191F, L497R, G306L, N29G, T167G, T164S, Q415H, T89A, L13D, R258T, and L13V, wherein the residue numbers are according to SEQ ID NO: 1.